Hemorheological abnormalities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity

被引:70
作者
Hitomi, A
Satoh, S
Ikegaki, I
Suzuki, Y
Shibuya, M
Asano, T
机构
[1] Asahi Chem Ind Co Ltd, Pharmacol Lab, Ohito 4102321, Japan
[2] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 4660065, Japan
[3] Chukyo Hosp, Dept Neurosurg, Nagoya, Aichi 4570866, Japan
关键词
blood viscosity; fasudil; protein kinase inhibitor; cerebral ischemia;
D O I
10.1016/S0024-3205(00)00781-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of this study was to investigate the mechanisms of the pathogenesis of hyperviscosity following cerebral ischemia, Focal ischemia was produced by embolic occlusion of the right middle cerebral artery (MCA) in rats for 1 hour, followed by recirculation. Twenty-four hours after MCA occlusion, fasudil, a protein kinase inhibitor, was administered intraperitoneally, Blood samples were taken from the abdominal aorta, and viscosity was measured using a cone-plate viscometer. The viscosity of whole blood in the ischemic attack group was significantly increased compared with the sham operated group 24 hours after MCA occlusion, Fasudil dose-dependently and significantly decreased the blood viscosity, and reduced to the normal range after administration of 10 mg/kg of fasudil (sham-operated rats, 5.17 +/- 0.05 cP; pre dose/ischemic rats, 6.05 +/- 0.08 cP; post dose/ischemic rats, 5.23 +/- 0.14 cP; 37.5 sec(-1)). Our findings suggest that cerebral ischemia induces a potent, systemic and longlasting hyperviscosity, and that the inhibition of protein kinases, especially rho kinase, is efficacious in preventing this hyperviscosity. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1929 / 1939
页数:11
相关论文
共 37 条
[1]   INHIBITION BY THE PROTEIN-KINASE INHIBITOR HA1077 OF THE ACTIVATION OF NADPH OXIDASE IN HUMAN NEUTROPHILS [J].
ARAI, M ;
SASAKI, Y ;
NOZAWA, R .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (08) :1487-1490
[2]   BLOCKADE OF INTRACELLULAR ACTIONS OF CALCIUM MAY PROTECT AGAINST ISCHEMIC DAMAGE TO THE GERBIL BRAIN [J].
ASANO, T ;
IKEGAKI, I ;
SATOH, S ;
MOCHIZUKI, D ;
HIDAKA, H ;
SUZUKI, Y ;
SHIBUYA, M ;
SUGITA, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (04) :1935-1938
[3]   VASODILATOR ACTIONS OF HA1077 INVITRO AND INVIVO PUTATIVELY MEDIATED BY THE INHIBITION OF PROTEIN-KINASE [J].
ASANO, T ;
SUZUKI, T ;
TSUCHIYA, M ;
SATOH, S ;
IKEGAKI, I ;
SHIBUYA, M ;
SUZUKI, Y ;
HIDAKA, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (04) :1091-1100
[4]  
ASANO T, 1987, J PHARMACOL EXP THER, V241, P1033
[5]   Activated polymorphonuclear leukocytes affect red blood cell aggregability [J].
Baskurt, OK ;
Meiselman, HJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (01) :89-93
[6]   CHRONIC BLOOD HYPERVISCOSITY IN SUBJECTS WITH ACUTE STROKE, TRANSIENT ISCHEMIC ATTACK, AND RISK-FACTORS FOR STROKE [J].
COULL, BM ;
BEAMER, N ;
DEGARMO, P ;
SEXTON, G ;
NORDT, F ;
KNOX, R ;
SEAMAN, GVF .
STROKE, 1991, 22 (02) :162-168
[7]  
GARCIA JH, 1994, AM J PATHOL, V144, P188
[8]   PHARMACOLOGICAL STUDIES ON THE TXA2 SYNTHETASE INHIBITOR (E)-3-[P-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-2-PROPENOIC ACID (OKY-046) [J].
HIRAKU, S ;
TANIGUCHI, K ;
WAKITANI, K ;
OMAWARI, N ;
KIRA, H ;
MIYAMOTO, T ;
OKEGAWA, T ;
KAWASAKI, A ;
UJIIE, A .
JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 41 (03) :393-401
[9]   THE EFFECTS OF CALCIUM-CHANNEL BLOCKERS ON BLOOD FLUIDITY [J].
KOENIG, W ;
ERNST, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 :S40-S44
[10]  
Koizumi J., 1986, JPN J STROKE, V8, P1, DOI [10.3995/jstroke.8.1, DOI 10.3995/JSTROKE.8.1]